Your session is about to expire
← Back to Search
Computed tomography perfusion for Brain Death
N/A
Waitlist Available
Led By Jai JS Shankar, MD, DM
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
In the present pilot study, the investigators propose to determine if performing CT perfusion scans in post-cardiac arrest patients in coma will help prognosticate the outcome in these patients.
Eligible Conditions
- Brain Death
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Clinical evaluation of brainstem function
Secondary outcome measures
Number of adverse events as a measure of safety and tolerability
Trial Design
1Treatment groups
Experimental Treatment
Group I: Computed tomography perfusionExperimental Treatment1 Intervention
Participants will undergo CT perfusion of the head after cooling following cardiac arrest.
Find a Location
Who is running the clinical trial?
Nova Scotia Health AuthorityLead Sponsor
259 Previous Clinical Trials
83,853 Total Patients Enrolled
Jai JS Shankar, MD, DMPrincipal InvestigatorQueen Elizabeth II Health Sciences Centre, Halifax Infirmary
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger